Higuchi Hirokazu, Hara Masatake, Yamamoto Kanjo, Miyamoto Tadashi, Kinoshita Makoto, Yamada Tasuku, Uchiyama Koji, Matsumori Akira
Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Japan.
Circulation. 2008 Jul 22;118(4):363-72. doi: 10.1161/CIRCULATIONAHA.107.741595. Epub 2008 Jul 7.
Mast cells are powerful producers of multiple cytokines and chemical mediators playing a pivotal role in the pathogenesis of various cardiovascular diseases. We examined the role of mast cells in murine models of heart failure due to viral myocarditis, using 2 strains of mast cell-deficient mice.
Two strains of mast cell-deficient mice, WBB6F1-Kit(W)/Kit(W-v) (W/W(V)) and WCB6F1-Kitl(Sl)/Kitl(Sl-d) (Sl/Sl(d)), were inoculated with 10 plaque-forming units of the encephalomyocarditis virus intraperitoneally. On day 14 after inoculation, survival of W/W(V) mice was significantly higher than that of their control littermates (77% versus 31%; P=0.03; n=13). On histological examination on day 7, myocardial necrosis and cellular infiltration were significantly less pronounced in W/W(V) and Sl/Sl(d) mice than in their control littermates (area of infiltration, 7.6+/-3.5% versus 29.3+/-15.6%; P=0.002; area of necrosis, 7.6+/-3.5% versus 30.0+/-17.2%; P=0.003; n=10). Histological examination showed more severe changes in mast cell-reconstituted than in -nonreconstituted W/W(V) and Sl/Sl(d) mice. The gene expressions of mast cell proteases were upregulated in the acute phase of viral myocarditis and rose further in the subacute phase of heart failure. Their activation coincided with the development of myocardial necrosis and fibrosis and correlated with the upregulation of gene expression of matrix metalloproteinase-9. The histamine H1-receptor antagonist bepotastine improved encephalomyocarditis viral myocarditis.
These observations suggest that mast cells participate in the acute inflammatory reaction and the onset of ventricular remodeling associated with acute viral myocarditis and that the inhibition of their function may be therapeutic in this disease.
肥大细胞是多种细胞因子和化学介质的强大产生者,在各种心血管疾病的发病机制中起关键作用。我们使用两株肥大细胞缺陷小鼠,研究了肥大细胞在病毒性心肌炎所致心力衰竭小鼠模型中的作用。
将两株肥大细胞缺陷小鼠,即WBB6F1-Kit(W)/Kit(W-v)(W/W(V))和WCB6F1-Kitl(Sl)/Kitl(Sl-d)(Sl/Sl(d)),经腹腔接种10个脑心肌炎病毒蚀斑形成单位。接种后第14天,W/W(V)小鼠的存活率显著高于其对照同窝小鼠(77%对31%;P = 0.03;n = 13)。在第7天进行组织学检查时,W/W(V)和Sl/Sl(d)小鼠的心肌坏死和细胞浸润明显轻于其对照同窝小鼠(浸润面积,7.6±3.5%对29.3±15.6%;P = 0.002;坏死面积,7.6±3.5%对30.0±17.2%;P = 0.003;n = 10)。组织学检查显示,与未重建肥大细胞的W/W(V)和Sl/Sl(d)小鼠相比,重建肥大细胞的小鼠变化更严重。肥大细胞蛋白酶的基因表达在病毒性心肌炎急性期上调,并在心力衰竭亚急性期进一步升高。它们的激活与心肌坏死和纤维化的发展同时发生,并与基质金属蛋白酶-9基因表达的上调相关。组胺H1受体拮抗剂贝波司汀改善了脑心肌炎病毒性心肌炎。
这些观察结果表明,肥大细胞参与了与急性病毒性心肌炎相关的急性炎症反应和心室重塑的发生,抑制其功能可能对该疾病具有治疗作用。